Contraception: What Every Internist Should Know

Medical Clinics of North America

Volumn 92, Issue 5, 2008, Pages 1037-1058

  Espey, Eve ^a   Ogburn, Tony ^a   Fotieo, Dana ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ETONOGESTREL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; SPERMICIDAL AGENT;

ABSTINENCE; CONDOM; CONTRACEPTION; EMERGENCY CONTRACEPTION; HEALTH EDUCATION; HORMONAL CONTRACEPTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SEXUAL EDUCATION; SOCIAL STATUS; UNPLANNED PREGNANCY; UTERINE CERVIX CAP; UTERINE TUBE STERILIZATION; VAGINA RING; VASECTOMY;

CONTRACEPTION; FEMALE; HUMANS; INTERNAL MEDICINE; PREGNANCY; PREGNANCY, UNPLANNED; SEX EDUCATION;

EID: 49549086405     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2008.05.001     Document Type: Review

References (48)

1. Finer L.B., and Henshaw S.K. Abortion incidence and services in the United States in 2000. Perspect Sex Reprod Health 35 1 (2003) 6-15
2. Finer L.B., and Henshaw S.K. Disparities in rates of unintended pregnancy in the United States. Perspect Sex Reprod Health 38 2 (2006) 90-96
3. Darroch J.E., Singh S., and Frost J.J. Differences in teenage pregnancy rates among five developed countries: the roles of sexual activity and contraceptive use. Fam Plann Perspect 33 6 (2001) 244-250 281
4. Espey E., Cosgrove E., and Ogburn T. Family planning American style: why it's so hard to control birth in the US. Obstet Gynecol Clin North Am 34 1 (2007) 1-17 vii [review]
5. Mosher W.D., Martinez G.M., Chandra A., et al. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data 350 (2004) 1-35
6. Duberstein L.L., Santelli J.S., and Singh S. Changes in formal sex education: 1995-2002. Perspect Sex Reprod Health 38 4 (2006) 182-189
7. SIECUS. Public support for sexuality education. Available at:. www.siecus.org/school/sex_ed/sex_ed0002 Accessed January 1, 2008
8. American College of Obstetricians and Gynecologists, and Committee on Adolescent Healthcare. Strategies for adolescent pregnancy prevention. Monograph. Washington, DC 2007. Available at:. http://www.acog.org/departments/dept_notice.cfm?recno=7&;bulletin=32 71 Accessed January 15, 2008
9. Singh S., and Darroch J.E. Adolescent pregnancy and childbearing: levels and trends in developed countries. Fam Plann Perspect 32 1 (2000) 14-23
10. Guttmacher Institute. Gap widening between U.S. women's birth control needs and government response. News release 3/1/2005. Available at:. http://www.guttmacher.org/media/nr/2005/02/22/index.html Accessed January 1, 2008
11. Centers for Disease Control and Prevention. Healthy people 2010 goals. Available at:. http://www.healthypeople.gov/document/HTML/tracking/OD09.html Accessed January 1, 2008
12. Guttmacher Institute. State policies in brief. Insurance coverage of contraceptives as of December 2007. Available at:. http://www.guttmacher.org/statecenter/spibs/spib_ICC.pdf Accessed January 1, 2008
13. Sonfield A., Benson R., Gold J., et al. U.S. Insurance coverage of contraceptives and the impact of contraceptive coverage mandates, 2002. Perspect Sex Reprod Health 36 2 (2004) 72-79
14. Phillips K.A., Stotland N.E., Liang S.Y., et al. Out-of-pocket expenditures for oral contraceptives and number of packs per purchase. J Am Med Womens Assoc 59 (2004) 36-42
15. Kunkel D., and Eyal K. Sex on TV 4 (2005), Kaiser Family Foundation, Menlo Park (CA)
16. Darroch J.E., Frost J., Singh S., et al. Teenage sexual and reproductive behavior in developed countries: can more progress be made? Guttmacher occasional report No. 3, 2001. Available at:. http://www.guttmacher.org/pubs/eurosynth_rpt.pdf Accessed January 1, 2008
17. Grimes D.A., and Schulz F.K. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 3 (1999) CD001327. 10.1002/14651858.CD001327
18. Walsh T., Grimes D., Frezieres R., et al. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD study group. Lancet 351 9108 (1998) 1005-1008
19. American College of Obstetricians and Gynecologists. Intrauterine device. Practice Bulletin No. 59, January 2005. Available at: http://www.acog.org/publications/educational_bulletins/pb059.cfm. Accessed June 30, 2008.
20. World Health Organization. Medical eligibility criteria for contraceptive use. 3rd edition (2004), WHO, Geneva (Switzerland)
21. Darney P, Patel A, Rosen K, et al. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2008, in press.
22. Hohman H., and Creinin M. The contraceptive implant. Clin Obstet Gynecol 50 4 (2007) 907-917
23. Power J., French R., and Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev 3 (2007) CD001326
24. Peterson H.B., Xia Z., Hughes J.M., et al. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 174 (1996) 1161-1170
25. Ogburn T., and Espey E. Transcervical sterilization: past, present, and future. Obstet Gynecol Clin North Am 34 1 (2007) 57-72
26. Cook L.A., Pun A., van Vliet H., et al. Scalpel versus no-scalpel incision for vasectomy. Cochrane Database Syst Rev 2 (2007) CD004112
27. Cook L.A., Van Vliet H., Lopez L.M., et al. Vasectomy occlusion techniques for male sterilization. Cochrane Database Syst Rev 2 (2007) CD003991
28. Royal College of Obstetricians and Gynaecologists. Male and female sterilisation. Evidence-Based guideline No. 4 (1999), RCOG Press, London
29. Trussell J. Contraceptive failure in the United States. Contraception 70 (2004) 89-96
30. Mishell Jr. D.R. Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med 41 (1996) 381-390
31. Curtis K.M., and Martins S.L. Progestogen-only contraception and bone mineral density: a systematic review. Contraception 73 (2006) 470-487
32. Kaunitz A., Arias R., and McClung M. Bone density recovery after depot medroxyprogesterone acetate injectable contraception use. Contraception 77 2 (2008) 67-76
33. Schwallie P.C., and Assenzo J.R. The effect of depot medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review. Contraception 10 (1974) 181-202
34. Speroff L., and Darney P. A clinical guide for contraception. 4th edition (2005), Lippincott Williams & Wilkins, Philadelphia 21-138
35. Harper J.C. Tailoring individualized treatment plans for acne. Cutis 81 1 Suppl (2008) 23-25
36. Collaborative Group on Epidemiological Studies of Ovarian Cancer, Brea V., Doll R., Hermon C., et al. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371 9609 (2008) 303-314
37. American College of Obstetricians and Gynecologists. Use of hormonal contraception in women with coexisting medical conditions. Practice Bulletin No. 73, 2006. Available at: http://www.acog.org/publications/educational_bulletins/pb073.cfm. Accessed June 30, 2008.
38. Curtis K.M., Chrisman C.E., Mohllajee A.P., et al. Effective use of hormonal contraceptives: Part I: combined oral contraceptive pills. Contraception 73 (2006) 115-124
39. Kiley J., and Hammond C. Combined oral contraceptives: a comprehensive review. Clin Obstet Gyn 50 4 (2007) 868-877
40. Edelman A.B., Gallo M.F., Jensen J.T., et al. Continuous or extended cycle versus cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev (2005) 3:CD004695
41. Urdl W., Apter D., and Alperstein A. Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol 121 (2005) 202-210
42. Zieman M., Guillebaud J., Weisberg E., et al. Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data. Fertil Steril 77 Suppl 2 (2002) S13-S18
43. Burkman R. Transdermal hormonal contraception: benefits and risks. Am J Obstet Gynecol 197 2 (2007) 134.e1-134.e6
44. Center for Disease Control. How effective are latex condoms in preventing HIV. Available at:. http://www.cdc.gov/hiv/resources/qa/condom.htm Accessed April 24, 2008
45. Kuyoh M.A., Toroitich-Ruto C., Grimes D.A., et al. Sponge versus diaphragm for contraception: a Cochrane review. Contraception 67 1): (2003) 15-18
46. von Hertzen H. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomized trial. Lancet 360 (2002) 1803-1809
47. American College of Obstetricians and Gynecologists. Emergency Contraception. Practice Bulletin No. 69, December 2005. Available at: http://www.acog.org/publications/educational_bulletins/pb069.cfm. Accessed June 30, 2008.
48. Zurawin R.K., and Ayensu-Coker L. Innovations in contraception: a review. Clin Obstet Gynecol 50 2 (2007) 425-439 [Review]